TL
Telix Pharmaceuticals Limited (TLX)
NASDAQ·Healthcare·Biotechnology
$10.44
+0.38%
Mkt Cap $2.54B
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+62.8%
Consensus $17.00 vs current $10.44